Cargando…

Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles

BACKGROUND: Although silver nanoparticles are currently used in more than 400 consumer products, it is not clear to what extent they induce adverse effects after inhalation during production and use. In this study, we determined the lung burden, tissue distribution, and the induction and recovery of...

Descripción completa

Detalles Bibliográficos
Autores principales: Braakhuis, Hedwig M, Gosens, Ilse, Krystek, Petra, Boere, John AF, Cassee, Flemming R, Fokkens, Paul HB, Post, Jan Andries, van Loveren, Henk, Park, Margriet VDZ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410796/
https://www.ncbi.nlm.nih.gov/pubmed/25227272
http://dx.doi.org/10.1186/s12989-014-0049-1
_version_ 1782368378276544512
author Braakhuis, Hedwig M
Gosens, Ilse
Krystek, Petra
Boere, John AF
Cassee, Flemming R
Fokkens, Paul HB
Post, Jan Andries
van Loveren, Henk
Park, Margriet VDZ
author_facet Braakhuis, Hedwig M
Gosens, Ilse
Krystek, Petra
Boere, John AF
Cassee, Flemming R
Fokkens, Paul HB
Post, Jan Andries
van Loveren, Henk
Park, Margriet VDZ
author_sort Braakhuis, Hedwig M
collection PubMed
description BACKGROUND: Although silver nanoparticles are currently used in more than 400 consumer products, it is not clear to what extent they induce adverse effects after inhalation during production and use. In this study, we determined the lung burden, tissue distribution, and the induction and recovery of adverse effects after short-term inhalation exposure to 15 nm and 410 nm silver nanoparticles. METHODS: Rats were nose-only exposed to clean air, 15 nm silver nanoparticles (179 μg/m(3)) or 410 nm silver particles (167 μg/m(3)) 6 hours per day, for four consecutive days. Tissue distribution and the induction of pulmonary toxicity were determined at 24 hours and 7 days after exposure and compared with the internal alveolar dose. Presence of silver nanoparticles in lung cells was visualized by transmission electron microscopy (TEM). RESULTS: Exposure to 15 nm silver nanoparticles induced moderate pulmonary toxicity compared to the controls, indicated by a 175-fold increased influx of neutrophils in the lungs, a doubling of cellular damage markers in the lungs, a 5-fold increase in pro-inflammatory cytokines, and a 1.5-fold increase in total glutathione at 24 hours after exposure. All the observed effects disappeared at 7 days after exposure. No effects were observed after exposure to 410 nm silver particles. The internal alveolar mass dose of the 15 nm nanoparticles was 3.5 times higher compared to the 410 nm particles, which equals to a 66,000 times higher particle number. TEM analysis revealed 15 nm nanoparticles in vesicles and nuclei of lung cells, which were decreased in size to <5 nm at 24 hours after exposure. This demonstrates substantial dissolution of the silver nanoparticles. CONCLUSION: The results show a clear size-dependent effect after inhalation of similar mass concentrations of 15 nm and 410 nm silver (nano)particles. This can be partially explained by the difference in the internal alveolar dose between the 15 nm and 410 nm silver (nano)particles as well as by a difference in the release rate of silver ions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-014-0049-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4410796
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44107962015-04-28 Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles Braakhuis, Hedwig M Gosens, Ilse Krystek, Petra Boere, John AF Cassee, Flemming R Fokkens, Paul HB Post, Jan Andries van Loveren, Henk Park, Margriet VDZ Part Fibre Toxicol Research BACKGROUND: Although silver nanoparticles are currently used in more than 400 consumer products, it is not clear to what extent they induce adverse effects after inhalation during production and use. In this study, we determined the lung burden, tissue distribution, and the induction and recovery of adverse effects after short-term inhalation exposure to 15 nm and 410 nm silver nanoparticles. METHODS: Rats were nose-only exposed to clean air, 15 nm silver nanoparticles (179 μg/m(3)) or 410 nm silver particles (167 μg/m(3)) 6 hours per day, for four consecutive days. Tissue distribution and the induction of pulmonary toxicity were determined at 24 hours and 7 days after exposure and compared with the internal alveolar dose. Presence of silver nanoparticles in lung cells was visualized by transmission electron microscopy (TEM). RESULTS: Exposure to 15 nm silver nanoparticles induced moderate pulmonary toxicity compared to the controls, indicated by a 175-fold increased influx of neutrophils in the lungs, a doubling of cellular damage markers in the lungs, a 5-fold increase in pro-inflammatory cytokines, and a 1.5-fold increase in total glutathione at 24 hours after exposure. All the observed effects disappeared at 7 days after exposure. No effects were observed after exposure to 410 nm silver particles. The internal alveolar mass dose of the 15 nm nanoparticles was 3.5 times higher compared to the 410 nm particles, which equals to a 66,000 times higher particle number. TEM analysis revealed 15 nm nanoparticles in vesicles and nuclei of lung cells, which were decreased in size to <5 nm at 24 hours after exposure. This demonstrates substantial dissolution of the silver nanoparticles. CONCLUSION: The results show a clear size-dependent effect after inhalation of similar mass concentrations of 15 nm and 410 nm silver (nano)particles. This can be partially explained by the difference in the internal alveolar dose between the 15 nm and 410 nm silver (nano)particles as well as by a difference in the release rate of silver ions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-014-0049-1) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-17 /pmc/articles/PMC4410796/ /pubmed/25227272 http://dx.doi.org/10.1186/s12989-014-0049-1 Text en © Braakhuis et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Braakhuis, Hedwig M
Gosens, Ilse
Krystek, Petra
Boere, John AF
Cassee, Flemming R
Fokkens, Paul HB
Post, Jan Andries
van Loveren, Henk
Park, Margriet VDZ
Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles
title Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles
title_full Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles
title_fullStr Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles
title_full_unstemmed Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles
title_short Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles
title_sort particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410796/
https://www.ncbi.nlm.nih.gov/pubmed/25227272
http://dx.doi.org/10.1186/s12989-014-0049-1
work_keys_str_mv AT braakhuishedwigm particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT gosensilse particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT krystekpetra particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT boerejohnaf particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT casseeflemmingr particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT fokkenspaulhb particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT postjanandries particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT vanloverenhenk particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles
AT parkmargrietvdz particlesizedependentdepositionandpulmonaryinflammationaftershortterminhalationofsilvernanoparticles